TCMBANKIN004503 |
clausine f |
|
C19H19NO3 |
309.4 g/mol |
CC(=CCC1=C2C3=CC=CC=C3NC2=C(C=C1C(=O)OC)O)C |
TCMBANKIN004977 |
zapoterin |
|
C26H30O8 |
470.5 g/mol |
CC1(C2CC(=O)C3(C(C2(C=CC(=O)O1)C)C(CC4(C35C(O5)C(=O)OC4C6=COC=C6)C)O)C)C |
TCMBANKIN006933 |
clausarin |
clausarin |
C24H28O4 |
380.5 g/mol |
CC1(C=CC2=C(O1)C(=C3C(=C2O)C=C(C(=O)O3)C(C)(C)C=C)C(C)(C)C=C)C |
TCMBANKIN011086 |
dentatin |
dentatin |
C20H22O4 |
326.4 g/mol |
CC1(C=CC2=C(C3=C(C(=C2O1)C(C)(C)C=C)OC(=O)C=C3)OC)C |
TCMBANKIN012379 |
nordentatin |
nordentatin |
C19H20O4 |
312.4 g/mol |
CC1(C=CC2=C(O1)C(=C3C(=C2O)C=CC(=O)O3)C(C)(C)C=C)C |
TCMBANKIN014850 |
Mukurozioside I |
mukurozioside i |
|
987.18 |
|
TCMBANKIN016105 |
clausine h |
|
C16H15NO4 |
285.29 g/mol |
COC1=CC2=C(C=C1)C3=CC(=C(C=C3N2)OC)C(=O)OC |
TCMBANKIN016433 |
clausenamide |
|
C18H19NO3 |
297.3 g/mol |
CN1C(C(C(C1=O)O)C2=CC=CC=C2)C(C3=CC=CC=C3)O |
TCMBANKIN017300 |
Glycozolidal |
2,7-dimethoxy-9H-carbazole-3-carboxaldehyde; glycozolidal; 2,7-dimethoxy-9H-carbazole-3-carbaldehyde; 9H-Carbazole-3-carboxaldehyde, 2,7-dimethoxy-; AIDS342644; AIDS-342644 |
C15H13NO3 |
255.27 g/mol |
COC1=CC2=C(C=C1)NC3=C2C=C(C(=C3)OC)C=O |
TCMBANKIN017987 |
clausine d |
|
C18H17NO2 |
279.3 g/mol |
CC(=CCC1=C2C3=CC=CC=C3NC2=C(C=C1C=O)O)C |
TCMBANKIN018772 |
murrayanine |
|
C14H11NO2 |
225.24 g/mol |
COC1=CC(=CC2=C1NC3=CC=CC=C32)C=O |
TCMBANKIN020191 |
murrayatin |
|
C20H26O6 |
362.4 g/mol |
CC(C)CC(=O)OC(CC1=C(C=CC2=C1OC(=O)C=C2)OC)C(C)(C)O |
TCMBANKIN023523 |
mukonal |
|
C13H9NO2 |
211.22 g/mol |
C1=CC=C2C(=C1)C3=C(N2)C=C(C(=C3)C=O)O |
TCMBANKIN025115 |
clausenin |
|
C14H12O5 |
260.24 g/mol |
CC1(CC(=O)C2=C(O1)C=C3C(=C2O)C=CC(=O)O3)C |
TCMBANKIN026284 |
clausine e |
|
C14H11NO3 |
241.24 g/mol |
COC(=O)C1=CC2=C(C(=C1)O)NC3=CC=CC=C32 |
TCMBANKIN030689 |
clausine i |
|
C14H11NO3 |
241.24 g/mol |
COC1=CC2=C(C=C1)NC3=C2C=C(C=C3O)C=O |
TCMBANKIN030786 |
clausenidin |
clausenidin |
C19H20O5 |
328.4 g/mol |
CC1(CC(=O)C2=C(O1)C(=C3C(=C2O)C=CC(=O)O3)C(C)(C)C=C)C |
TCMBANKIN031860 |
clausine k |
|
C15H13NO4 |
271.27 g/mol |
COC1=CC2=C(C=C1)C3=CC(=C(C=C3N2)OC)C(=O)O |
TCMBANKIN031979 |
clavatine |
|
C16H25NO2 |
|
CC1CC2CC(=O)C3(CCCN4C3(C1)C2CCC4)O |
TCMBANKIN033442 |
clausine b |
|
C15H13NO4 |
271.27 g/mol |
COC1=CC2=C(C(=C1)OC)NC3=C2C=C(C(=C3)O)C=O |
TCMBANKIN036868 |
Glycycoumarin |
AIDS-060354; MolPort-039-101-203; AKOS026674269; LMPK12160018; DTXSID20241630; AC1NSW00; glycycoumarin; AK168532; 3-(2,4-dihydroxyphenyl)-7-hydroxy-5-methoxy-6-(3-methylbut-2-enyl)-2-chromenone; AIDS060354; 3-(2,4-Dihydroxyphenyl)-7-hydroxy-5-methoxy-6-(3-methyl-2-butenyl)-2H-1-benzopyran-2-one, 9CI; 3-(2,4-Dihydroxy-phenyl)-7-hydroxy-5-methoxy-6-(3-methyl-but-2-enyl)-1-benzopyran-2-one; 3-(2,4-dihydroxyphenyl)-7-hydroxy-5-methoxy-6-(3-methylbut-2-enyl)coumarin; SCHEMBL759406; 94805-82-0; BDBM50325943; 3-(2,4-dihydroxyphenyl)-7-hydroxy-5-methoxy-6-(3-methylbut-2-enyl)chromen-2-one; ZINC15262009; CHEMBL1223642; CHEBI:69087; 3-(2,4-dihydroxyphenyl)-7-hydroxy-5-methoxy-6-(3-methylbut-2-en-1-yl)-2H-chromen-2-one |
C21H20O6 |
368.38 |
CC(=CCC1=C(C2=C(C=C1O)OC(=O)C(=C2)C3=C(C=C(C=C3)O)O)OC)C |
TCMBANKIN038016 |
clausine q |
|
C14H11NO3 |
241.24 g/mol |
COC1=CC(=CC2=C1NC3=C2C=CC(=C3)O)C=O |
TCMBANKIN038613 |
Zearalenone |
F-2 toxin |
|
318.4 g/mol |
|
TCMBANKIN039612 |
3-METHYLCARBAZOLE |
3-methyl carbazole; 9H-Carbazole, 3-methyl-; SCHEMBL262221; ZINC1869244; MFCD00464338; FT-0692230; NSC-10154; KB-32618; AIDS287167; 3-Methyl-9H-carbazole; CHEMBL1173768; 6-methylcarbazole; 4630-20-0; PHKYYUQQYARDIU-UHFFFAOYSA-N; M2561; NSC10154; Carbazole, 3-methyl-; NSC 10154; AIDS-287167; CTK1D6259; AC1L2GWU; 3-methylcarbazole; 9H-Carbazole,3-methyl-; EINECS 225-048-1; CJ-30668; BG01201402; AKOS003654161; ZINC01869244; 3-Methyl-9H-carbazole #; AK555380; DTXSID90196805 |
C13H11N |
181.23 |
CC1=CC2=C(C=C1)NC3=CC=CC=C32 |
TCMBANKIN040375 |
Clausine V |
|
|
227.26 g/mol |
|
TCMBANKIN040556 |
1-Hydroxymethyl-beta-carboline |
1-hydroxymethyl-β-carboline |
C12H10N2O |
198.221 |
c1([H])c([H])c([H])c(c(c([H])c([H])nc2C([H])([H])O[H])c2n3[H])c3c1[H] |
TCMBANKIN040688 |
clausine p |
|
C15H15NO2 |
241.28 g/mol |
CC1=CC2=C(C=C1OC)NC3=C2C=CC=C3OC |
TCMBANKIN041185 |
clausine s |
|
C18H17NO3 |
295.3 g/mol |
CC(=C)C(CC1=C(C(=CC2=C1NC3=CC=CC=C32)C=O)O)O |
TCMBANKIN041254 |
2-hydroxy-3-o-tigloylswietenolide |
|
C32H40O10 |
|
CC=C(C)C(=O)OC1C(C(C2(C3CCC4(C(OC(=O)CC4=C3CC1(C2=O)O)C5=COC=C5)C)C)C(C(=O)OC)O)(C)C |
TCMBANKIN041780 |
trans-Methyl p-coumarate |
|
|
|
|
TCMBANKIN042179 |
mukonine |
|
C15H13NO3 |
255.27 g/mol |
COC1=CC(=CC2=C1NC3=CC=CC=C32)C(=O)OC |
TCMBANKIN042469 |
Clausine O |
|
|
227.21 g/mol |
|
TCMBANKIN044672 |
Clausine U |
|
|
329.3 g/mol |
|
TCMBANKIN045096 |
Heptaphylline |
2-hydroxy-1-(3-methylbut-2-enyl)-9H-carbazole-3-carbaldehyde; 2-hydroxy-1-(3-methylbut-2-enyl)-9H-carbazole-3-carboxaldehyde; heptaphylline |
C18H17NO2 |
279.3 g/mol |
CC(=CCC1=C(C(=CC2=C1NC3=CC=CC=C32)C=O)O)C |
TCMBANKIN047039 |
Clausenatine A |
|
|
349.5 g/mol |
|
TCMBANKIN048023 |
Clausine N |
|
|
241.24 g/mol |
|
TCMBANKIN048544 |
Methyl carbazole-3-carboxylate |
|
|
225.24 g/mol |
|
TCMBANKIN049983 |
clausine r |
|
C14H11NO4 |
257.24 g/mol |
COC(=O)C1=CC2=C(C(=C1)O)NC3=C2C=CC(=C3)O |
TCMBANKIN050199 |
Clausine M |
|
|
241.24 g/mol |
|
TCMBANKIN058372 |
indole-3-carboxaldehyde |
3-Formylindole; Indole-3-carbaldehyde; beta-Indolylaldehyde; 3-Indolealdehyde; 246045-99-8; SBB004120; AI3-52407; Indol-3-carboxaldehyde; NSC10118; 487-89-8; BRN 0114117; 5-21-08-00246 (Beilstein Handbook Reference); 1H-indole-3-carbaldehyde; 3-formylindole; 1H-Indole-3-carboxaldehyde; C08493; AIDS-019632; Indole-3-carboxaldehyde; 3-Indolecarboxaldehyde; INDOLE-3-CARBOXYALDEHYDE; .beta.-Indolylaldehyde; EINECS 207-665-8; AIDS019632; NSC 10118; 57210_FLUKA; 3-Indolecarbaldehyde; ZINC00087959; NCGC00161738-01; BAS 07339836; INDOLE-3-ALDEHYDE; 129445_ALDRICH |
C9H7NO |
145.16 g/mol |
C1=CC=C2C(=C1)C(=CN2)C=O |
TCMBANKIN058924 |
brevifolin |
brevifolin ; BSPBio_001701; Brevifolin; Brevifolin (VAN); AQ-358/42007313; SPBio_000566; 4,6-Dimethoxy-2-hydroxyacetophenone; NSC17392; SDCCGMLS-0066937.P001; 1-(2-Hydroxy-4,6-dimethoxyphenyl)ethan-1-one; 477-94-1; 90-24-4; 2'-Hydroxy-4',6'-dimethoxyacetophenone; KBio2_006193; Spectrum2_000463; AIDS-027830; Brevifolin[Geranium]; ST5308751; Xanthoxyline; C10726; Acetophenone, 2'-hydroxy-4',6'-dimethoxy- (8CI); KBioGR_002137; CTK8I8351; KBio2_003625; AI3-26010; SpecPlus_000713; KBio1_001753; Phloracetophenone dimethyl ether; DivK1c_006809; 1-(2-hydroxy-4,6-dimethoxyphenyl)ethanone; AIDS027830; 1-(2-hydroxy-4,6-dimethoxy-phenyl)ethanone; Spectrum5_000237; Spectrum_000577; 2-Hydroxy-4,6-dimethoxyacetophenone; KBioSS_001057; Brevifolin (Zanthoxylum); SCHEMBL10339420; Phloroacetophenone 2,4-dimethyl ether; Spectrum4_001499; NSC 17392; KBio3_001201; ZINC00157077; Acetophenone der.; SPECTRUM200441; Acetophenone, 2'-hydroxy-4',6'-dimethoxy-; EINECS 201-978-3; Ethanone, 1-(2-hydroxy-4,6-dimethoxyphenyl)-; Xanthoxylin; 630586_ALDRICH; 1,2-Dihydro-7,8,9-trihydroxycyclopenta[c][2]benzopyran-3,5-dione; 2,4-Di-O-methylphloroacetophenone; 2′-Hydroxy-4′,6′-dimethoxyacetophenone; NCGC00095824-01; Spectrum3_000181; KBio2_001057;xanthoxylin;RTR-030636; SDCCGMLS-0066937.P001; AKOS015856339; FT-0612544; SpecPlus_000713; AI3-26010; KB-146755; ACMC-209r5b; 1-(2-hydroxy-4,6-dimethoxy-phenyl)ethanone; 4, 6-Dimethoxy-2-hydroxyacetophenone; A-8021; 4',6'-dimethoxy-2'-hydroxyacetophenone; 2-Hydroxyl-4,6-dimethoxy-acetophenone; NCGC00095824-02; Spectrum4_001499; 1-Acetyl-2-hydroxy-4,6-dimethoxybenzene; MCULE-4292389127; D2683; ST24037116; 2,4-Di-O-methylphloroacetophenone; Spectrum3_000181; NCGC00095824-01; KBio2_001057; (2-hydroxy-4,6-dimethoxy-phenyl)-ethanone; SR-05000002434; 1-(2-Hydroxy-4,6-dimethoxyphenyl)ethan-1-one; Spectrum2_000463; KBio2_006193; ST098711; Xanthoxyline; KS-000012GK; C10726; FCH1116672; 4CN-0948; ZB006545; ZINC157077; Spectrum5_000237; OR22374; NSC 17392; CHEBI:10070; KBio3_001201; Ethanone, 1-(2-hydroxy-4,6-dimethoxyphenyl)-; AJ-14872; 2-Hydroxy-4, 6-dimethoxyacetophenone; BSPBio_001701; AB1004782; Brevifolin; SR-05000002434-1; FBUBVLUPUDBFME-UHFFFAOYSA-N; Brevifolin (VAN); 4,6-Dimethoxy-2-hydroxyacetophenone; CTK3J0177; 2'-Hydroxy-4',6'-dimethoxyacetophenone; TRA0050729; AK135500; MFCD00017243; NSC-17392; I14-19971; KBioGR_002137; DTXSID10237981; KBio2_003625; AC1Q5D4Z; KBio1_001753; Acetophenone,6'-dimethoxy-; DivK1c_006809; KBioSS_001057; Brevifolin (Zanthoxylum); BRD-K12260308-001-02-6; SPECTRUM200441; Acetophenone der.; 2-Acetyl-3,5-dimethoxyphenol; SMR001306755; Xanthoxylin; 1-(2-Hydroxy-4,6-dimethoxyphenyl)ethanone #; AQ-358/42007313; SPBio_000566; NSC17392; Brevifolin; 4',6'-Dimethoxy-2'-hydroxyacetophenone; 90-24-4; 2'-hyroxy-4',6'-dimethoxyacetophenone; SBB071509; Acetophenone, 2'-hydroxy-4',6'-dimethoxy- (8CI); SCHEMBL44708; AC1L25UT; MLS002207182; ANW-39453; 1-(2-hydroxy-4,6-dimethoxyphenyl)-ethanone; Phloracetophenone dimethyl ether; UNII-Z8RSY5TZPA; ZX-AT021196; Spectrum_000577; 2-Hydroxy-4,6-dimethoxyacetophenone; 2''-HYDROXY-4'',6''-DIMETHOXYACETOPHENONE; AX8000172; Phloroacetophenone 2,4-dimethyl ether; CHEMBL450288; 6-Methoxypaeonol; SC-69796; 2'-Hydroxy-4',6'-dimethoxyacetophenone, 97%; Acetophenone, 2'-hydroxy-4',6'-dimethoxy-; EINECS 201-978-3; Z8RSY5TZPA; 1-(2-Hydroxy-4,6-dimethoxyphenyl)ethanone; CCG-38702; MolPort-001-762-282; 2-hydroxy-4,6-dimethoxyacetophenone; TR-030636; brevifolin(van); 2'-Hydroxy-4',6'-dimethoxy-Acetophenone |
C10H12O4 |
196.2 |
CC(=O)C1=C(C=C(C=C1OC)OC)O |
TCMBANKIN059481 |
dentatin |
|
C20H22O4 |
326.4 g/mol |
CC1(C=CC2=C(C3=C(C(=C2O1)C(C)(C)C=C)OC(=O)C=C3)OC)C |
TCMBANKIN059486 |
xanthoxyletin |
|
C15H14O4 |
258.27 g/mol |
CC1(C=CC2=C(O1)C=C3C(=C2OC)C=CC(=O)O3)C |
TCMBANKIN060819 |
2-heptenal;E-2-Heptenal;cis-Hept-2-enal;trans-2-heptenal;(E)-2- heptenal;Heptenal;beta-heptenal;(Z)-2-heptenal;2- Heptenal,(E)-;alpha-heptenal |
|
C7H12O |
112.17 g/mol |
CCCCC=CC=O |
TCMBANKIN061423 |
methyl-3-(β-carboline-1-yl)propionate |
methyl-3-(belta-carboline-1-yl)propionate |
C15H14N2O2 |
|
COC(=O)CCC1=NC=CC2=C1NC3=CC=CC=C23 |
TCMBANKIN061474 |
3, 4-dimethoxybenzaldehyde |
DSSTox_CID_6285; Verapamil Impurity G; 4,3-dimethoxybenzaldehyde; D0507; RTC-010113; BBL010373; SBB040236; AH-034/32845024; F2190-0618; Benzaldehyde, 3,4-dimethoxy-; 3,4-dimethoxybenzaldehyde (veratraldehyde); FT-0600118; FEMA 3109; AC1Q4FDU; LS-628; BC622797; Veratrumaldehyde; 107052-EP2374783A1; BR-46721; 3,4-DIMETHOXYBENZALDEHHYDE; ACN-051072; NCGC00091642-02; Vanillin methyl ether; 3,4-Dimethoxybenzenecarbonal; AM20050100; Protocatechuecaldehyde dimethyl ether; ST45169641; 3,4-Dimethoxybenzaldehyde, 99%; VERATRALDEHYDE; p-Veratric aldehyde; AB1000043; TIMTEC-BB SBB040236; DSSTox_GSID_26285; Protocatechuic aldehyde dimethyl ether; CCRIS 6285; ACT06905; LABOTEST-BB LT00235863; I01-2283; Protocatechualdehyde dimethyl ether; OTAVA-BB 1180632; VERATRYLALDEHYDE; CTK0H5284; PubChem8238; KB-28345; InChI=1/C9H10O3/c1-11-8-4-3-7(6-10)5-9(8)12-2/h3-6H,1-2H; 107052-EP2295423A1; ANW-17460; ZB006061; NSC-8500; AC1Q46T0; WLN: VHR CO1 DO1; DTXSID7026285; AS-11996; Veratrum aldehyde; 3,4-Dimethoxy benzaldehyde; CHEMBL1088937; MFCD00003363; Tox21_201566; STK188425; 4CN-0811; TL806334; DSSTox_RID_78087; 3,4-dimethoxybenzaldeyde; NCGC00257217-01; Benzaldehyde, 3,4-dimethoxy-veratraldehyde; 3,4-Dimethoxybenzaldehyde (Verapamil Related Compound E - USP), Pharmaceutical Secondary Standard; Certified Reference Material; KSC175E8J; BB_NC-2052; Vanillin methyl ether; Veratraldehyde; AC1L1QYK; NSC 24521; 3,4dimethoxybenzaldehyde; NSC24521; NCGC00259115-01; AKOS000118989; Benzaldehyde,4-dimethoxy-; 4-O-Methylvanillin; AI3-08099; Veratric aldehyde; 3,4-dimethoxybenzaidehyde; 107052-EP2377841A1; CM13990; RP22905; UI88P68JZD; AKOS BBS-00003208; SCHEMBL25202; TC-010113; bmse010220; LABOTEST-BB LT03331050; MolPort-000-871-214; WJUFSDZVCOTFON-UHFFFAOYSA-N; Methylvanillin; AS02987; NSC8500; ST2410267; UNII-UI88P68JZD; BRN 0473899; 107052-EP2298744A2; AN-22815; KS-00000AZ9; MCULE-1202068347; 120-14-9; NE10275; NSC-24521; TRA0003531; 4,5-dimethoxybenzaldehyde; AC-10201; 3,4-DIMETHOXY-BENZALDEHYDE; C02201; CAS-120-14-9; DB-014213; 3,4-Dimethoxybenzaldehyde; CHEBI:17098; NCGC00091642-01; 3, 4-Dimethoxybenzaldehyde; AJ-13584; 3,4 dimethoxybenzaldehyde; FEMA No. 3109; Veratral; CJ-01437; Veratraldehyde, >=98%, FG; ACMC-209a6e; NCGC00091642-03; AK-46721; Tox21_303074; W-108485; ZINC155456; CS-W019906; SC-00570; Verapamil Related Compound E, United States Pharmacopeia (USP) Reference Standard; EINECS 204-373-2; Veratryl aldehyde; ST5213394; AH-034/32845024; InChI=1/C9H10O3/c1-11-8-4-3-7(6-10)5-9(8)12-2/h3-6H,1-2H; 3,4-Dimethoxybenzaldehyde; Benzaldehyde, 3,4-dimethoxy-; 94860_FLUKA; CHEBI:17098; WLN: VHR CO1 DO1; C02201; NCGC00091642-01; Veratrum aldehyde; NCGC00091642-02; Vanillin methyl ether; Methylvanillin; FEMA No. 3109; 3,4-Dimethoxybenzenecarbonal; Protocatechuecaldehyde dimethyl ether; W310905_ALDRICH; NSC8500; ZINC00155456; p-Veratric aldehyde; BRN 0473899; Veratraldehyde; Protocatechuic aldehyde dimethyl ether; CCRIS 6285; 120-14-9; NSC24521; NSC 24521; 4-O-Methylvanillin; 4-08-00-01765 (Beilstein Handbook Reference); AI3-08099; 143758_ALDRICH; Protocatechualdehyde dimethyl ether; Veratric aldehyde; EINECS 204-373-2; 3,4-DIMETHOXY-BENZALDEHYDE; Veratryl aldehyde; veratraldehyde; methylvanillin; Veratral |
C9H10O3 |
166.17 g/mol |
COC1=C(C=C(C=C1)C=O)OC |